Oocyte vitrification is an attractive and efficient option in the long-term management of endometriosis patients. Which women would benefit from banked oocytes when pregnancy is attempted, and whether oocyte vitrification should be carried out before or after the surgical management of endometriosis, is still debated. On the basis of recent data, and in the absence of cost-effective modelling, a personalized strategy should assess crucial variables, such as type of surgery, effect on oocyte yield and the huge heterogeneity of the clinical scenarios possibly requiring surgery. Research into a more tailored approach to maximize the result of each available intervention, e.g. hormones, surgery, assisted reproductive technology or their combination to prevent infertility and reduce the actual burden of personal and societal cost of the disease, is recommended.

在子宫内膜异位症患者的长期管理中，卵母细胞玻璃化冷冻是一种有吸引力且有效的选择。哪些女性在尝试怀孕时会从储存的卵母细胞中受益，以及是否应该在子宫内膜异位症的手术治疗之前或之后进行卵母细胞玻璃化冷冻，仍然存在争议。根据最近的数据，并且在缺乏具有成本效益的建模的情况下，个性化策略应该评估关键变量，例如手术类型、对卵母细胞产量的影响以及可能需要手术的临床情况的巨大异质性。研究更量身定制的方法，以最大限度地提高每种可用干预措施的结果，例如激素、手术、辅助生殖技术或它们的组合，以预防不孕症并减少疾病的个人和社会成本的实际负担，